Dexamethasone inhibits the induction of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase by phorbol ester in human promonocytic U937 cells.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2000-06-02

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0167-4889(00)00039-2PMID 10838159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclic AMP response element mediates dexamethasone induced suppression of prostaglandin H synthase-2 gene expression in human amnion derived WISH cells.

  1999cited by this paper
• Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo.

  1997cited by this paper
• Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?

  1997cited by this paper
• Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors

  1997cited by this paper
• Characterization of the genomic structure and promoter of the mouse NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene.

  1997cited by this paper
• A New Function for the C-terminal Zinc Finger of the Glucocorticoid Receptor

  1997cited by this paper
• 1,25-dihydroxyvitamin D3 induces NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase in human neonatal monocytes.

  1997cited by this paper
• Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction

  1996cited by this paper
• Prostaglandin synthase 2.

  1996cited by this paper
• Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells.

  1995cited by this paper
• Selective Induction of Prostaglandin G/H Synthase I by Stem Cell Factor and Dexamethasone in Mast Cells (*)

  1995cited by this paper
• Regulation of two isozymes of prostaglandin endoperoxide synthase and thromboxane synthase in human monoblastoid cell line U937.

  1995cited by this paper
• Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils.

  1995cited by this paper
• A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP‐1.

  1994cited by this paper
• Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.

  1994cited by this paper
• Lipoxin A4 metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products.

  1993cited by this paper
• Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (COX-1).

  1993cited by this paper
• Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts.

  1992cited by this paper
• The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer?

  1992cited by this paper
• Stimulation of synthesis de novo of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase in human promyelocytic leukaemia (HL-60) cells by phorbol ester.

  1991cited by this paper
• Regulation of synthesis and activity of NAD(+)-dependent 15-hydroxy-prostaglandin dehydrogenase (15-PGDH) by dexamethasone and phorbol ester in human erythroleukemia (HEL) cells.

  1991cited by this paper
• The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.

  1991cited by this paper
• Monoclonal antibodies that inhibit the enzyme activity of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase.

  1990cited by this paper
• Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells.

  1987cited by this paper
• Domains of the glucocorticoid receptor involved in specific and nonspecific deoxyribonucleic acid binding, hormone activation, and transcriptional enhancement.

  1987cited by this paper
• Oxidation of 15-hydroxyeicosatetraenoic acid and other hydroxy fatty acids by lung prostaglandin dehydrogenase.

  1987cited by this paper
• Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor.

  1987cited by this paper
• sn-1,2-Diacylglycerols and phorbol diesters stimulate thromboxane synthesis by de novo synthesis of prostaglandin H synthase in human promyelocytic leukemia cells.

  1987cited by this paper
• Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase.

  1986cited by this paper
• 12-L-hydroxy-5,8,10-heptadecatrienoic acid (HHT) is an excellent substrate for NAD+-dependent 15-hydroxyprostaglandin dehydrogenase.

  1985cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979cited by this paper
• Enzymatic synthesis of (15s)-[15-3h]prostaglandins and their use in the development of a simple and sensitive assay for 15-hydroxyprostaglandin dehydrogenase.

  1976cited by this paper
• The distribution of 15-hydroxy prostaglandin dehydrogenase and prostaglandin-delta 13-reductase in tissues of the swine.

  1971cited by this paper
• The Distribution of 15-Hydroxy Prosta-glandin Dehydrogenase and Prostaglandin-Δ13-Reductase in Tissues of the Swine

  1971cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• The biological activities of three metabolites of prostaglandin E 1.

  1966cited by this paper
• The Biological Activities of Three Metabolites of Prostaglandin E1

  1966cited by this paper
• PROSTAGLANDINS AND RELATED FACTORS. 28. METABOLISM OF PROSTAGLANDIN E1 IN GUINEA PIG LUNG: THE STRUCTURES OF TWO METABOLITES.

  1964cited by this paper

• Uterine and placental expression of HPGD in cows during pregnancy and release of fetal membranes

  2019cites this paper
• Uterine and placental expression of HPGD in cows during pregnancy and release of fetal membranes.

  2017cites this paper
• High-mobility group box 1 suppresses resolvin D1-induced phagocytosis via induction of resolvin D1-inactivating enzyme, 15-hydroxyprostaglandin dehydrogenase.

  2015cites this paper
• Limited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue

  2012cites this paper
• 15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy.

  2011cites this paper
• Opposite Effect of Phorbol Ester PMA on PTGS2 and PGDH mRNA Expression in Human Chorion Trophoblast Cells

  2008cites this paper
• Endogenous pro‐resolving and anti‐inflammatory lipid mediators: a new pharmacologic genus

  2008cites this paper
• Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells.

  2006cites this paper
• 15-Hydroxyprostaglandin dehydrogenase can be induced by dexamethasone and other glucocorticoids at the therapeutic level in A549 human lung adenocarcinoma cells.

  2005cites this paper
• Suppression of 15-Hydroxyprostaglandin Dehydrogenase Messenger RNA Concentration, Protein Expression, and Enzymatic Activity during Human Ureteral Obstruction

  2004cites this paper
• Mechanism of cortisol/progesterone antagonism in the regulation of 15-hydroxyprostaglandin dehydrogenase activity and messenger ribonucleic acid levels in human chorion and placental trophoblast cells at term.

  2003cites this paper
• IL‐10 expression profiling in human monocytes

  2002cites this paper
• Prostaglandin catabolizing enzymes.

  2002cites this paper
• Oxidoreductases in Lipoxin A4 Metabolic Inactivation

  2000cites this paper